Artwork

Content provided by VoiceAmerica and Dr. Rebecca Risk. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by VoiceAmerica and Dr. Rebecca Risk or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Low Dose Naltrexone with Linda Elsegood

57:28
 
Share
 

Archived series ("Inactive feed" status)

When? This feed was archived on May 10, 2020 05:08 (4y ago). Last successful fetch was on March 10, 2020 15:05 (4y ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 221030076 series 1243668
Content provided by VoiceAmerica and Dr. Rebecca Risk. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by VoiceAmerica and Dr. Rebecca Risk or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
After Low Dose Naltrexone helped Linda Elsegood with her progressive MS, she took it on as a personal mission to bring more information to the general public about this amazing drug. She founded the LDN Research Trust, and is discussing her new book “The LDN Book: How a Little Known Generic Drug—Low Dose Naltrexone—could revolutionize treatment for Autoimmune diseases, Cancer, Autism, Depression and More” in this interview.
  continue reading

216 episodes

Artwork
iconShare
 

Archived series ("Inactive feed" status)

When? This feed was archived on May 10, 2020 05:08 (4y ago). Last successful fetch was on March 10, 2020 15:05 (4y ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 221030076 series 1243668
Content provided by VoiceAmerica and Dr. Rebecca Risk. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by VoiceAmerica and Dr. Rebecca Risk or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
After Low Dose Naltrexone helped Linda Elsegood with her progressive MS, she took it on as a personal mission to bring more information to the general public about this amazing drug. She founded the LDN Research Trust, and is discussing her new book “The LDN Book: How a Little Known Generic Drug—Low Dose Naltrexone—could revolutionize treatment for Autoimmune diseases, Cancer, Autism, Depression and More” in this interview.
  continue reading

216 episodes

Todos os episódios

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide